Mark Groves

1.2k total citations
14 papers, 286 citations indexed

About

Mark Groves is a scholar working on Cellular and Molecular Neuroscience, Neurology and Clinical Psychology. According to data from OpenAlex, Mark Groves has authored 14 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 10 papers in Neurology and 4 papers in Clinical Psychology. Recurrent topics in Mark Groves's work include Genetic Neurodegenerative Diseases (11 papers), Neurological disorders and treatments (9 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Mark Groves is often cited by papers focused on Genetic Neurodegenerative Diseases (11 papers), Neurological disorders and treatments (9 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Mark Groves collaborates with scholars based in United States, United Kingdom and France. Mark Groves's co-authors include David Craufurd, Karen E. Anderson, Erik van Duijn, Daniël P. van Kammen, LaVonne Goodman, Nathan Goodman, Mary Edmondson, Christina A Palmese, Vicki Shanker and Jane S. Paulsen and has published in prestigious journals such as Movement Disorders, Journal of Psychiatric Research and Journal of Neuropsychiatry.

In The Last Decade

Mark Groves

14 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Groves United States	8	224	221	86	37	35	14	286
Mary Edmondson United States	7	181 0.8×	226 1.0×	113 1.3×	56 1.5×	28 0.8×	15	287
Jesús Ruiz‐Idiago Spain	8	200 0.9×	211 1.0×	86 1.0×	44 1.2×	39 1.1×	15	289
LaVonne Goodman United States	7	226 1.0×	289 1.3×	124 1.4×	33 0.9×	29 0.8×	11	317
Ida Unmack Larsen Denmark	8	104 0.5×	143 0.6×	69 0.8×	42 1.1×	22 0.6×	14	203
Caroline K. Jurgens Netherlands	10	197 0.9×	242 1.1×	151 1.8×	53 1.4×	28 0.8×	12	346
S. Genitrini Italy	10	255 1.1×	210 1.0×	88 1.0×	16 0.4×	85 2.4×	16	374
M Sakamoto Japan	5	160 0.7×	112 0.5×	75 0.9×	20 0.5×	68 1.9×	8	280
M. Mavridis France	5	147 0.7×	290 1.3×	116 1.3×	44 1.2×	29 0.8×	7	347
Elisa Unti Italy	10	205 0.9×	106 0.5×	54 0.6×	35 0.9×	21 0.6×	18	293
Banashree Mondal India	7	149 0.7×	70 0.3×	67 0.8×	22 0.6×	64 1.8×	28	252

Countries citing papers authored by Mark Groves

Since Specialization

Citations

This map shows the geographic impact of Mark Groves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Groves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Groves more than expected).

Fields of papers citing papers by Mark Groves

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Groves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Groves. The network helps show where Mark Groves may publish in the future.

Co-authorship network of co-authors of Mark Groves

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Groves. A scholar is included among the top collaborators of Mark Groves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Groves. Mark Groves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Groves, Mark. (2017). The highly anxious individual presenting for Huntington disease-predictive genetic testing: the psychiatrist's role in assessment and counseling. Handbook of clinical neurology. 144. 99–105. 2 indexed citations

Palmese, Christina A, et al.. (2016). Psychiatric and Cognitive Effects of Deep Brain Stimulation for Parkinson’s Disease. Current Neurology and Neuroscience Reports. 16(10). 87–87. 24 indexed citations

Anderson, Karen E., Shirley Eberly, Mark Groves, et al.. (2016). Risk Factors for Suicidal Ideation in People at Risk for Huntington’s Disease. Journal of Huntington s Disease. 5(4). 389–394. 16 indexed citations

Liang, John, Mark Groves, & Vicki Shanker. (2015). Clozapine Treatment for Impulse Control Disorders in Parkinson's Disease Patients: A Case Series. Movement Disorders Clinical Practice. 2(3). 283–285. 5 indexed citations

Epping, Eric A., James A. Mills, Leigh J. Beglinger, et al.. (2013). Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study. Journal of Psychiatric Research. 47(10). 1423–1431. 51 indexed citations

Vaccarino, Anthony L., Terrence Sills, Karen E. Anderson, et al.. (2011). Assessment of Depression, Anxiety and Apathy in Prodromal and Early Huntington Disease. PLoS Currents. 3. RRN1242–RRN1242. 11 indexed citations

Groves, Mark, Erik van Duijn, Karen E. Anderson, et al.. (2011). An International Survey-based Algorithm for the Pharmacologic Treatment of Irritability in Huntington's Disease. PLoS Currents. 3. RRN1259–RRN1259. 80 indexed citations

Anderson, Karen E., David Craufurd, Mary Edmondson, et al.. (2011). An International Survey-based Algorithm for the Pharmacologic Treatment of Obsessive-Compulsive Behaviors in Huntington’s Disease. PLoS Currents. 3. RRN1261–RRN1261. 42 indexed citations

Shanker, Vicki, Mark Groves, Gary A. Heiman, et al.. (2011). Mood and cognition in leucine‐rich repeat kinase 2 G2019S Parkinson's disease. Movement Disorders. 26(10). 1875–1880. 33 indexed citations

10.

Vaccarino, Anthony L., Karen E. Anderson, Beth Borowsky, et al.. (2011). Assessing Behavioural Manifestations Prior to Clinical Diagnosis of Huntington Disease: "Anger and Irritability" and "Obsessions and Compulsions". PLoS Currents. 3. RRN1241–RRN1241. 5 indexed citations

11.

Groves, Mark & David V. Forrest. (2005). Parkinson's disease as a model for psychosocial issues in chronic neurodegenerative disease.. PubMed. 96. 65–83. 5 indexed citations

12.

Groves, Mark. (2004). Mental and Behavioral Dysfunction in Movement Disorders. Journal of Neuropsychiatry. 16(4). 539–542. 10 indexed citations

13.

Groves, Mark. (2004). Mental and Behavioral Dysfunction in Movement Disorders. Journal of Neuropsychiatry. 16(4). 539–542. 1 indexed citations

14.

Groves, Mark, Jean‐Paul Vonsattel, Pietro Mazzoni, & Karen Marder. (2003). Huntington's Disease. Science of Aging Knowledge Environment. 2003(43). dn3–dn3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact